Filing Details

Accession Number:
0001477932-24-007970
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-12-10 16:01:16
Reporting Period:
2024-12-09
Accepted Time:
2024-12-10 16:01:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
93314 Volitionrx Ltd VNRX In Vitro & In Vivo Diagnostic Substances (2835) 911949078
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1651671 Vincent Jacob Micallef 1489 West Warm Springs Road
Suite 110
Henderson NV 89014
Chief Scientific Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-12-09 43,691 $0.57 394,352 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 55,000 Indirect By Spouse
Common Stock 38,113 Indirect By Borlaug Limited
Footnotes
  1. Acquired at the offering price in the registered direct offering of Common Stock by VolitionRx.
  2. The shares of common stock are held directly by Borlaug Limited. The reporting person is a controlling director of Borlaug Limited and has voting and dispositive control over the shares of common stock held by Borlaug Limited.